Form D · Other Health Care
Convergent Dental, Inc.
Waltham, MA · CIK 0001532437
Offering snapshot reported May 5, 2023 · SEC filing
- Reported sold
- $10.1M Indefinite offering
- Investors reported
- 39 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 5, 2023 | Initial | $10,136,176 | No comparison | 39 | SEC filing |
| Jul 21, 2022 | Amendment | $43,664,674 | $3,664,674vs Aug 27, 2021 | 20 | SEC filing |
| Aug 27, 2021 | Initial | $40,000,000 | No comparison | Not reported | SEC filing |
| Sep 10, 2019 | Initial | $8,000,004 | No comparison | 2 | SEC filing |
| Oct 14, 2016 | Amendment | $27,740,538 | $6,825,367vs Jan 22, 2016 | 114 | SEC filing |
| Jan 22, 2016 | Amendment | $20,915,171 | $15,442,638vs Mar 28, 2014 | 92 | SEC filing |
| Mar 28, 2014 | Initial | $5,472,533 | No comparison | 56 | SEC filing |
| Jun 12, 2013 | Amendment | $7,395,005 | $4,720,001vs Dec 19, 2012 | 50 | SEC filing |
| Dec 19, 2012 | Initial | $2,675,004 | No comparison | 11 | SEC filing |
| Oct 11, 2011 | Initial | $2,167,613 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-480973
The total amount sold included the conversion of certain convertible promissory notes previously issued by the Issuer.
Source: Form D, filed May 5, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael J. Cataldo | Director, Executive |
| Mark Collins | Executive |
| William Cowen | Director |
| Bart Doedens | Director |
| Robert Gershon | Director, Executive |
| Grant Gund | Director |
| Leonard Hedge | Director |
| Len Hedge | Director |
| Richard Lazara | Director |
| Richard Lazzara | Director |
| Nathan P. Monty | Director, Executive |
| Word Peak | Director |
| Timothy Petersen | Director |
| Warren Thaler | Director |
| Jhung Vojir | Executive |
| Kelsey Wirth | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
100 Fifth Avenue Suite 1010
Waltham, MA, 02451
Waltham, MA, 02451